The First Affiliated Hospital of Anhui Medical University

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

1 drugs in development

Phase 21

By Therapeutic Area

top 1

Oncology

1100%

R&D Momentum

59/100

Pipeline Velocity

30/100

Trial Completion Rate

89/100

Pipeline Concentration

100/100

Pipeline Freshness

70/100

Activity

Recent Activity

Last 14 days

Nov 5, 2026

Recruiting

A Multicenter Randomized Controlled Trial Evaluating AI-Assisted Intensive Lifestyle Intervention Versus Tirzepatide for Glycemic and Weight Management in Patients With Obesity and Newly Diagnosed Type 2 Diabetes

Nov 4, 2026

Recruiting

Exploratory Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of UX-DA003 Injection (Human iPSC-derived Midbrain Dopaminergic Neural Precursor Cells) in Patients With Parkinson's Disease

Earlier

Oct 8, 2026TrialIntravenous Recombinant Human Prourokinase for Acute Medium Vessel Occlusion 4.5-24 Hours After Ischemic Stroke - A Multicenter, Prospective, Randomized, Open-label, Blinded Endpoint Trial（HOPE-MeVO）

Aug 27, 2026TrialA Prospective Multicenter Cohort Registry Study of Intravenous Recombinant Human Prourokinase for Acute Ischemic Stroke Within 4.5 Hours of Symptom Onset (PRISM)

Aug 12, 2026TrialThe Efficacy and Safety of Temporal Interference Stimulation on Motor Symptoms of Parkinson's Disease: A Three-arm, Randomized, Double-blind, Parallel-controlled Study

Aug 6, 2026TrialThe Rebound Effect on Repeated Low-Level Red Light Therapy for Myopia: A Randomized Controlled Clinical Trial

Aug 5, 2026TrialAn Open-Label, Single-Arm, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Alpha-0261 Tablets in Patients With Moderate to Severe Active Ulcerative Colitis (UC)

Jul 18, 2026TrialStudy on the Efficacy and Neural Mechanisms of Transcranial Direct Current Stimulation Targeting the Supplementary Motor Area for the Treatment of Subacute Post-stroke Aphasia

4 more events

Jul 2, 2026TrialStudy on Early Visual Dysfunction in Patients With Systemic Lupus Erythematosus

Dec 1, 2025TrialDose-escalation of Rectal Indomethacin for Preventing PEP

Oct 1, 2025TrialRemiazolam vs Propofol Total Intravenous Anesthesia on Postoperative Neurodevelopment After General Anesthesia in Children

Aug 1, 2025TrialEvaluation of the Efficacy of rhBNP in Patients With Diuretic Resistance After Cardiac Surgery